======= ASAH2 ======= == Gene Information == * **Official Symbol**: ASAH2 * **Official Name**: N-acylsphingosine amidohydrolase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56624|56624]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NR71|Q9NR71]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ASAH2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ASAH2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611202|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid at an optimal pH of 6.5-8.5. Acts as a key regulator of sphingolipid signaling metabolites by generating sphingosine at the cell surface. Acts as a repressor of apoptosis both by reducing C16-ceramide, thereby preventing ceramide-induced apoptosis, and generating sphingosine, a precursor of the antiapoptotic factor sphingosine 1-phosphate. Probably involved in the digestion of dietary sphingolipids in intestine by acting as a key enzyme for the catabolism of dietary sphingolipids and regulating the levels of bioactive sphingolipid metabolites in the intestinal tract. {ECO:0000269|PubMed:15946935, ECO:0000269|PubMed:16061940}. |Ceramidase alk| |ceramidase activity| |N-acylsphingosine amidohydrolase activity| |sphingosine biosynthetic process| |sphingoid biosynthetic process| |sphingosine metabolic process| |lipid digestion| |sphingoid metabolic process| |diol biosynthetic process| |ceramide catabolic process| |diol metabolic process| |long-chain fatty acid biosynthetic process| |sphingolipid catabolic process| |membrane lipid catabolic process| |ceramide biosynthetic process| |polyol biosynthetic process| |caveola| |ceramide metabolic process| |sphingolipid biosynthetic process| |polyol metabolic process| |digestion| |alcohol biosynthetic process| |long-chain fatty acid metabolic process| |fatty acid biosynthetic process| |membrane lipid biosynthetic process| |sphingolipid metabolic process| |organic hydroxy compound biosynthetic process| |monocarboxylic acid biosynthetic process| |ammonium ion metabolic process| |cellular lipid catabolic process| |membrane lipid metabolic process| |membrane raft| |negative regulation of apoptotic signaling pathway| |lipid catabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |alcohol metabolic process| |fatty acid metabolic process| |regulation of apoptotic signaling pathway| |organic hydroxy compound metabolic process| |amide biosynthetic process| |monocarboxylic acid metabolic process| |lipid biosynthetic process| |small molecule biosynthetic process| |Golgi membrane| |regulation of mitotic cell cycle| |calcium ion binding| |cellular amide metabolic process| |zinc ion binding| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |carboxylic acid metabolic process| |apoptotic process| |cellular lipid metabolic process| |Golgi apparatus| |negative regulation of cell death| |oxoacid metabolic process| |cellular response to cytokine stimulus| |organic acid metabolic process| |programmed cell death| |organonitrogen compound catabolic process| |cell death| |response to cytokine| |regulation of cell cycle| |lipid metabolic process| |mitochondrion| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |integral component of plasma membrane| |organonitrogen compound biosynthetic process| |regulation of apoptotic process| |regulation of programmed cell death| |negative regulation of response to stimulus| |cellular nitrogen compound biosynthetic process| |regulation of cell death| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.82| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.609| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11333 * **Expression level (log2 read counts)**: -0.07 {{:chemogenomics:nalm6 dist.png?nolink |}}